Maryland Tech Council Bio-Innovation Conference 2025

The GW Technology Commercialization Office (TCO) participated in this year's Maryland Tech Council’s 2025 Bio Innovation Conference, held on September 4 at the Bethesda North Marriott Hotel & Conference Center. Hosted by the Maryland Tech Council, the event brought together biotech leaders, researchers, investors, and policymakers from across the Mid-Atlantic and beyond to explore the latest breakthroughs shaping the future of life sciences and health innovation. Throughout the day, attendees engaged in a full program of panels and roundtables covering critical industry topics - from AI in clinical research and biomanufacturing innovation to non-dilutive funding strategies and U.S. life science cluster growth. Highlights included a fireside chat with FDA Commissioner Dr. Marty Makary, sessions on accessing capital in a risk-averse environment, and an institutional investor keynote on the power of storytelling to drive company value.

Image

As an exhibitor, TCO was excited to meet innovators, entrepreneurs, and potential partners throughout the conference. Our team shared how GW research continues to advance biotechnology and healthcare through novel discoveries, patents, and startup ventures. Events like the Bio Innovation Conference reinforce GW’s commitment to supporting translational research and building connections between academia and industry.